Induction of Antitumor Acquired Immunity by Baculovirus Autographa californica Multiple Nuclear Polyhedrosis Virus Infection in Mice
- 1 February 2008
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 15 (2), 376-378
- https://doi.org/10.1128/cvi.00285-07
Abstract
The baculovirus Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) has been studied as a gene therapy vector. Here, we demonstrated that AcMNPV induces antitumor acquired immunity. These results suggest that AcMNPV has the potential to be an efficient virus or tumor therapy agent which induces innate and acquired immunity.Keywords
This publication has 23 references indexed in Scilit:
- Induction of Natural Killer Cell-dependent Antitumor Immunity by the Autographa californica Multiple Nuclear Polyhedrosis VirusMolecular Therapy, 2008
- Characterization of baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mammalian cellsBiochemical and Biophysical Research Communications, 2006
- Cytotoxic T CellsJournal of Investigative Dermatology, 2006
- Strategies of Antigen-Specific T-Cell–Based Immunotherapy for CancerCancer Biotherapy & Radiopharmaceuticals, 2005
- Involvement of the Toll-Like Receptor 9 Signaling Pathway in the Induction of Innate Immunity by BaculovirusJournal of Virology, 2005
- Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in miceGene Therapy, 2003
- Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin)Experimental & Molecular Medicine, 2001
- Field trial of a genetically improved baculovirus insecticideNature, 1994
- Construction of an improved baculovirus insecticide containing an insect-specific toxin geneNature, 1991
- Baculovirus Expression Vectors: the Requirements for High Level Expression of Proteins, Including GlycoproteinsJournal of General Virology, 1987